LeafLink's Bold Pivot: Flat Fees, Simplified Tiers, and a New Financial Frontier

LeafLink's Bold Pivot: Flat Fees, Simplified Tiers, and a New Financial Frontier
Blunt Business
Enjoy this episode?
Subscribe to Blunt Business for new episodes.

LeafLink's Bold Pivot: Flat Fees, Simplified Tiers, and a New Financial Frontier
Blunt Business
Enjoy this episode?
Subscribe to Blunt Business for new episodes.

Blunt Business
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.